Treating Alzheimer’s Disease (AD) with Light and Sound
Treating Alzheimer’s Disease (AD) with Light and Sound
复制标题
DOI:
--
复制
发表时间:
2020-02
期刊:
影响因子:
--
通讯作者:
W. Lukiw
中科院分区:
文献类型:
--
作者:
W. Lukiw
Normal human brain functions through the complex acquisition, coordination, integration and processing of multiple and different afferent inputs and amongst the most prominent and important of these are the environmentally/externally-sourced input of light and sound. Together visual and acoustic stimulation accounts for about ~85% of the afferent input to the human brain. The natural generation of gamma oscillations in the brain between 25 Hz and 140 Hz from this coordinated and integrated neural activity are thought to underlie multiple brain functions as diverse as attention, behavior, cognitive processing and memory. These natural oscillations, sometimes referred to as biological rhythms or biorhythms, may be significantly disrupted as we age and especially so in insidious, age-related, progressive and ultimately lethal neurological disorders such as Alzheimer’s Disease (AD) and frontotemporal dementia (FTD). The recent research work by Li-Huei Tsai’s research group at MIT on combined acoustic and visual gamma oscillation entrainment and its significantly positive effects on the cognitive functions of neural cell networks raises the intriguing possibility that artificial visual and acoustic stimulation of the brain can be successfully exploited to preserve both neural connectivity, neuronal densities and synaptic signalling function and elicit significant neuroprotection against progressive, age-related inflammatory and degenerative neuropathology [1].